Boston Scientific | BSX - Ebit

Stock Price
60.84
Daily Change
-1.23 -1.98%
Monthly
-12.81%
Yearly
-40.29%
Q2 Forecast
60.74

Boston Scientific reported $1.24B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
CONMED USD 36.62M 24.74M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
Illumina USD 256M 6M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025